"Designing Growth Strategies is in our DNA"

Bacterial Vaccines Market Size, Share & Industry Analysis, By Type (Recombinant/Conjugate/Subunit, Inactivated, Live Attenuated, Toxoid, and Others), By Route of Administration (Parenteral and Oral), By Age Group (Pediatrics and Adults), By Indication (Meningococcal Disease, Pneumococcal Disease, Diphtheria/Tetanus/Pertussis, and Others), By Distribution Channel (Hospital & Retail Pharmacies, Government Suppliers, and Others), and Regional Forecast, 2025-2032

Last Updated: November 17, 2025 | Format: PDF | Report ID: FBI113652

 

We will customize the report to meet your research goals, helping you gain a competitive edge, and make informed decisions.

  1. Introduction
    1. Research Scope
    2. Market Segmentation
    3. Research Methodology
    4. Definitions and Assumptions
  2. Executive Summary
  3. Market Dynamics
    1. Market Drivers
    2. Market Restraints
    3. Market Opportunities
    4. Market Trends
  4. Key Insights
    1. Incidence/Prevalence of Key Diseases, By Key Countries/Regions, 2024
    2. Pipeline Analysis, By Key Players
    3. Technological Advancements in the Bacterial Vaccines
    4. New Product Launches, By Key Players
    5. Key Industry Developments Such as Mergers, Acquisitions, and Partnerships
  5. Global Bacterial Vaccines Market Analysis, Insights and Forecast, 2019-2032
    1. Market Analysis, Insights and Forecast – By Type
      1. Recombinant/Conjugate/Subunit
      2. Inactivated
      3. Live Attenuated
      4. Toxoid
      5. Others
    2. Market Analysis, Insights and Forecast – By Route of Administration
      1. Parenteral
      2. Oral
    3. Market Analysis, Insights and Forecast – By Age Group
      1. Pediatrics
      2. Adolts
    4. Market Analysis, Insights and Forecast – By Indication
      1. Meningococcal Disease
      2. Pneumococcal Disease
      3. Diphtheria/Tetanus/Pertussis
      4. Others
    5. Market Analysis, Insights and Forecast – By Distribution Channel
      1. Hospital & Retail Pharmacies
      2. Government Suppliers
      3. Others
    6. Market Analysis, Insights and Forecast – By Region
      1. North America
      2. Europe
      3. Asia Pacific
      4. Latin America
      5. Middle East & Africa 
  6. North America Bacterial Vaccines Market Analysis, Insights and Forecast, 2019-2032
    1. Market Analysis, Insights and Forecast – By Type
      1. Recombinant/Conjugate/Subunit
      2. Inactivated
      3. Live Attenuated
      4. Toxoid
      5. Others
    2. Market Analysis, Insights and Forecast – By Route of Administration
      1. Parenteral
      2. Oral
    3. Market Analysis, Insights and Forecast – By Age Group
      1. Pediatrics
      2. Adolts
    4. Market Analysis, Insights and Forecast – By Indication
      1. Meningococcal Disease
      2. Pneumococcal Disease
      3. Diphtheria/Tetanus/Pertussis
      4. Others
    5. Market Analysis, Insights and Forecast – By Distribution Channel
      1. Hospital & Retail Pharmacies
      2. Government Suppliers
      3. Others
    6. Market Analysis, Insights and Forecast – By Country
      1. U.S.
      2. Canada
  7. Europe Bacterial Vaccines Market Analysis, Insights and Forecast, 2019-2032
    1. Market Analysis, Insights and Forecast – By Type
      1. Recombinant/Conjugate/Subunit
      2. Inactivated
      3. Live Attenuated
      4. Toxoid
      5. Others
    2. Market Analysis, Insights and Forecast – By Route of Administration
      1. Parenteral
      2. Oral
    3. Market Analysis, Insights and Forecast – By Age Group
      1. Pediatrics
      2. Adolts
    4. Market Analysis, Insights and Forecast – By Indication
      1. Meningococcal Disease
      2. Pneumococcal Disease
      3. Diphtheria/Tetanus/Pertussis
      4. Others
    5. Market Analysis, Insights and Forecast – By Distribution Channel
      1. Hospital & Retail Pharmacies
      2. Government Suppliers
      3. Others
    6. Market Analysis, Insights and Forecast – By Country/Sub-Region
      1. U.K.
      2. Germany
      3. France
      4. Spain
      5. Italy
      6. Scandinavia
      7. Rest of Europe 
  8. Asia Pacific Bacterial Vaccines Market Analysis, Insights and Forecast, 2019-2032
    1. Market Analysis, Insights and Forecast – By Type
      1. Recombinant/Conjugate/Subunit
      2. Inactivated
      3. Live Attenuated
      4. Toxoid
      5. Others
    2. Market Analysis, Insights and Forecast – By Route of Administration
      1. Parenteral
      2. Oral
    3. Market Analysis, Insights and Forecast – By Age Group
      1. Pediatrics
      2. Adolts
    4. Market Analysis, Insights and Forecast – By Indication
      1. Meningococcal Disease
      2. Pneumococcal Disease
      3. Diphtheria/Tetanus/Pertussis
      4. Others
    5. Market Analysis, Insights and Forecast – By Distribution Channel
      1. Hospital & Retail Pharmacies
      2. Government Suppliers
      3. Others
    6. Market Analysis, Insights and Forecast – By Country/Sub-Region
      1. Japan
      2. China
      3. India
      4. Australia
      5. Southeast Asia
      6. Rest of Asia Pacific
  9. Latin America Bacterial Vaccines Market Analysis, Insights and Forecast, 2019-2032
    1. Market Analysis, Insights and Forecast – By Type
      1. Recombinant/Conjugate/Subunit
      2. Inactivated
      3. Live Attenuated
      4. Toxoid
      5. Others
    2. Market Analysis, Insights and Forecast – By Route of Administration
      1. Parenteral
      2. Oral
    3. Market Analysis, Insights and Forecast – By Age Group
      1. Pediatrics
      2. Adolts
    4. Market Analysis, Insights and Forecast – By Indication
      1. Meningococcal Disease
      2. Pneumococcal Disease
      3. Diphtheria/Tetanus/Pertussis
      4. Others
    5. Market Analysis, Insights and Forecast – By Distribution Channel
      1. Hospital & Retail Pharmacies
      2. Government Suppliers
      3. Others
    6. Market Analysis, Insights and Forecast – By Country/Sub-Region
      1. Brazil
      2. Mexico
      3. Rest of Latin America 
  10. Middle East & Africa Bacterial Vaccines Market Analysis, Insights and Forecast, 2019-2032
    1. Market Analysis, Insights and Forecast – By Type
      1. Recombinant/Conjugate/Subunit
      2. Inactivated
      3. Live Attenuated
      4. Toxoid
      5. Others
    2. Market Analysis, Insights and Forecast – By Route of Administration
      1. Parenteral
      2. Oral
    3. Market Analysis, Insights and Forecast – By Age Group
      1. Pediatrics
      2. Adolts
    4. Market Analysis, Insights and Forecast – By Indication
      1. Meningococcal Disease
      2. Pneumococcal Disease
      3. Diphtheria/Tetanus/Pertussis
      4. Others
    5. Market Analysis, Insights and Forecast – By Distribution Channel
      1. Hospital & Retail Pharmacies
      2. Government Suppliers
      3. Others
    6. Market Analysis, Insights and Forecast – By Country/Sub-Region
      1. GCC
      2. South Africa
      3. Rest of Middle East & Africa
  11. Competitive Analysis
    1. Global Market Share Analysis (2024)
    2. Company Profiles
      1. Sanofi
        1. Overview
        2. Products
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability)
      2. GSK plc.
        1. Overview
        2. Products
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability)
      3. Merck & Co., Inc.
        1. Overview
        2. Products
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability)
      4. Bharat Biotech
        1. Overview
        2. Products
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability)
      5. Pfizer Inc.
        1. Overview
        2. Products
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability)
      6. Emergent BioSolutions, Inc.
        1. Overview
        2. Products
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability)
      7. Serum Institute of india Pvt. Ltd.
        1. Overview
        2. Products
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability)
      8. BIO-MED
        1. Overview
        2. Products
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability)
  1. Introduction
    1. Research Scope
    2. Market Segmentation
    3. Research Methodology
    4. Definitions and Assumptions
  2. Executive Summary
  3. Market Dynamics
    1. Market Drivers
    2. Market Restraints
    3. Market Opportunities
    4. Market Trends
  4. Key Insights
    1. Incidence/Prevalence of Key Diseases, By Key Countries/Regions, 2024
    2. Pipeline Analysis, By Key Players
    3. Technological Advancements in the Bacterial Vaccines
    4. New Product Launches, By Key Players
    5. Key Industry Developments Such as Mergers, Acquisitions, and Partnerships
  5. Global Bacterial Vaccines Market Analysis, Insights and Forecast, 2019-2032
    1. Market Analysis, Insights and Forecast – By Type
      1. Recombinant/Conjugate/Subunit
      2. Inactivated
      3. Live Attenuated
      4. Toxoid
      5. Others
    2. Market Analysis, Insights and Forecast – By Route of Administration
      1. Parenteral
      2. Oral
    3. Market Analysis, Insights and Forecast – By Age Group
      1. Pediatrics
      2. Adolts
    4. Market Analysis, Insights and Forecast – By Indication
      1. Meningococcal Disease
      2. Pneumococcal Disease
      3. Diphtheria/Tetanus/Pertussis
      4. Others
    5. Market Analysis, Insights and Forecast – By Distribution Channel
      1. Hospital & Retail Pharmacies
      2. Government Suppliers
      3. Others
    6. Market Analysis, Insights and Forecast – By Region
      1. North America
      2. Europe
      3. Asia Pacific
      4. Latin America
      5. Middle East & Africa 
  6. North America Bacterial Vaccines Market Analysis, Insights and Forecast, 2019-2032
    1. Market Analysis, Insights and Forecast – By Type
      1. Recombinant/Conjugate/Subunit
      2. Inactivated
      3. Live Attenuated
      4. Toxoid
      5. Others
    2. Market Analysis, Insights and Forecast – By Route of Administration
      1. Parenteral
      2. Oral
    3. Market Analysis, Insights and Forecast – By Age Group
      1. Pediatrics
      2. Adolts
    4. Market Analysis, Insights and Forecast – By Indication
      1. Meningococcal Disease
      2. Pneumococcal Disease
      3. Diphtheria/Tetanus/Pertussis
      4. Others
    5. Market Analysis, Insights and Forecast – By Distribution Channel
      1. Hospital & Retail Pharmacies
      2. Government Suppliers
      3. Others
    6. Market Analysis, Insights and Forecast – By Country
      1. U.S.
      2. Canada
  7. Europe Bacterial Vaccines Market Analysis, Insights and Forecast, 2019-2032
    1. Market Analysis, Insights and Forecast – By Type
      1. Recombinant/Conjugate/Subunit
      2. Inactivated
      3. Live Attenuated
      4. Toxoid
      5. Others
    2. Market Analysis, Insights and Forecast – By Route of Administration
      1. Parenteral
      2. Oral
    3. Market Analysis, Insights and Forecast – By Age Group
      1. Pediatrics
      2. Adolts
    4. Market Analysis, Insights and Forecast – By Indication
      1. Meningococcal Disease
      2. Pneumococcal Disease
      3. Diphtheria/Tetanus/Pertussis
      4. Others
    5. Market Analysis, Insights and Forecast – By Distribution Channel
      1. Hospital & Retail Pharmacies
      2. Government Suppliers
      3. Others
    6. Market Analysis, Insights and Forecast – By Country/Sub-Region
      1. U.K.
      2. Germany
      3. France
      4. Spain
      5. Italy
      6. Scandinavia
      7. Rest of Europe 
  8. Asia Pacific Bacterial Vaccines Market Analysis, Insights and Forecast, 2019-2032
    1. Market Analysis, Insights and Forecast – By Type
      1. Recombinant/Conjugate/Subunit
      2. Inactivated
      3. Live Attenuated
      4. Toxoid
      5. Others
    2. Market Analysis, Insights and Forecast – By Route of Administration
      1. Parenteral
      2. Oral
    3. Market Analysis, Insights and Forecast – By Age Group
      1. Pediatrics
      2. Adolts
    4. Market Analysis, Insights and Forecast – By Indication
      1. Meningococcal Disease
      2. Pneumococcal Disease
      3. Diphtheria/Tetanus/Pertussis
      4. Others
    5. Market Analysis, Insights and Forecast – By Distribution Channel
      1. Hospital & Retail Pharmacies
      2. Government Suppliers
      3. Others
    6. Market Analysis, Insights and Forecast – By Country/Sub-Region
      1. Japan
      2. China
      3. India
      4. Australia
      5. Southeast Asia
      6. Rest of Asia Pacific
  9. Latin America Bacterial Vaccines Market Analysis, Insights and Forecast, 2019-2032
    1. Market Analysis, Insights and Forecast – By Type
      1. Recombinant/Conjugate/Subunit
      2. Inactivated
      3. Live Attenuated
      4. Toxoid
      5. Others
    2. Market Analysis, Insights and Forecast – By Route of Administration
      1. Parenteral
      2. Oral
    3. Market Analysis, Insights and Forecast – By Age Group
      1. Pediatrics
      2. Adolts
    4. Market Analysis, Insights and Forecast – By Indication
      1. Meningococcal Disease
      2. Pneumococcal Disease
      3. Diphtheria/Tetanus/Pertussis
      4. Others
    5. Market Analysis, Insights and Forecast – By Distribution Channel
      1. Hospital & Retail Pharmacies
      2. Government Suppliers
      3. Others
    6. Market Analysis, Insights and Forecast – By Country/Sub-Region
      1. Brazil
      2. Mexico
      3. Rest of Latin America 
  10. Middle East & Africa Bacterial Vaccines Market Analysis, Insights and Forecast, 2019-2032
    1. Market Analysis, Insights and Forecast – By Type
      1. Recombinant/Conjugate/Subunit
      2. Inactivated
      3. Live Attenuated
      4. Toxoid
      5. Others
    2. Market Analysis, Insights and Forecast – By Route of Administration
      1. Parenteral
      2. Oral
    3. Market Analysis, Insights and Forecast – By Age Group
      1. Pediatrics
      2. Adolts
    4. Market Analysis, Insights and Forecast – By Indication
      1. Meningococcal Disease
      2. Pneumococcal Disease
      3. Diphtheria/Tetanus/Pertussis
      4. Others
    5. Market Analysis, Insights and Forecast – By Distribution Channel
      1. Hospital & Retail Pharmacies
      2. Government Suppliers
      3. Others
    6. Market Analysis, Insights and Forecast – By Country/Sub-Region
      1. GCC
      2. South Africa
      3. Rest of Middle East & Africa
  11. Competitive Analysis
    1. Global Market Share Analysis (2024)
    2. Company Profiles
      1. Sanofi
        1. Overview
        2. Products
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability)
      2. GSK plc.
        1. Overview
        2. Products
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability)
      3. Merck & Co., Inc.
        1. Overview
        2. Products
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability)
      4. Bharat Biotech
        1. Overview
        2. Products
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability)
      5. Pfizer Inc.
        1. Overview
        2. Products
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability)
      6. Emergent BioSolutions, Inc.
        1. Overview
        2. Products
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability)
      7. Serum Institute of india Pvt. Ltd.
        1. Overview
        2. Products
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability)
      8. BIO-MED
        1. Overview
        2. Products
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability)
Read Less

Figure 1:  Global Bacterial Vaccines Market Revenue Breakdown (USD billion, %) by Region, 2024 & 2032

Figure 2:  Global Bacterial Vaccines Market Value Share (%), by Type, 2024 & 2032

Figure 3:  Global Bacterial Vaccines Market Value Share (%), by Route of Administration, 2024 & 2032

Figure 4:  Global Bacterial Vaccines Market Value Share (%), by Age Group, 2024 & 2033

Figure 5:  Global Bacterial Vaccines Market Value Share (%), by Indication, 2024 & 2034

Figure 6:  Global Bacterial Vaccines Market Value Share (%), by Distribution Channel, 2024 & 2032

Figure 7:  Global Bacterial Vaccines Market Value Share (%), by Region, 2024 & 2032

Figure 8:  North America Bacterial Vaccines Market Value (USD billion), by Type, 2024 & 2032

Figure 9:  North America Bacterial Vaccines Market Value Share (%), by Type, 2024

Figure 10:  North America Bacterial Vaccines Market Value (USD billion), by Route of Administration, 2024 & 2032

Figure 11:  North America Bacterial Vaccines Market Value Share (%), by Route of Administration, 2024

Figure 12:  North America Bacterial Vaccines Market Value (USD billion), by Age Group, 2024 & 2032

Figure 13:  North America Bacterial Vaccines Market Value Share (%), by Age Group, 2024

Figure 14:  North America Bacterial Vaccines Market Value (USD billion), by Indication, 2024 & 2032

Figure 15:  North America Bacterial Vaccines Market Value Share (%), by Indication, 2024

Figure 16:  North America Bacterial Vaccines Market Value (USD billion), by Distribution Channel, 2024 & 2032

Figure 17:  North America Bacterial Vaccines Market Value Share (%), by Distribution Channel, 2024

Figure 18:  North America Bacterial Vaccines Market Value (USD billion), By Country, 2024 & 2032

Figure 19:  North America Bacterial Vaccines Market Value Share (%), By Country, 2024

Figure 20:  Europe Bacterial Vaccines Market Value (USD billion), by Type, 2024 & 2032

Figure 21:  Europe Bacterial Vaccines Market Value Share (%), by Type, 2024

Figure 22:  Europe Bacterial Vaccines Market Value (USD billion), by Route of Administration, 2024 & 2032

Figure 23:  Europe Bacterial Vaccines Market Value Share (%), by Route of Administration, 2024

Figure 24:  Europe Bacterial Vaccines Market Value (USD billion), by Age Group, 2024 & 2032

Figure 25:  Europe Bacterial Vaccines Market Value Share (%), by Age Group, 2024

Figure 26:  Europe Bacterial Vaccines Market Value (USD billion), by Indication, 2024 & 2032

Figure 27:  Europe Bacterial Vaccines Market Value Share (%), by Indication, 2024

Figure 28:  Europe Bacterial Vaccines Market Value (USD billion), by Distribution Channel, 2024 & 2032

Figure 29:  Europe Bacterial Vaccines Market Value Share (%), by Distribution Channel, 2024

Figure 30:  Europe Bacterial Vaccines Market Value (USD billion), By Country/ Sub-region, 2024 & 2032

Figure 31:  Europe Bacterial Vaccines Market Value Share (%), By Country/ Sub-region, 2024

Figure 32:  Asia Pacific Bacterial Vaccines Market Value (USD billion), by Type, 2024 & 2032

Figure 33:  Asia Pacific Bacterial Vaccines Market Value Share (%), by Type, 2024

Figure 34:  Asia Pacific Bacterial Vaccines Market Value (USD billion), by Route of Administration, 2024 & 2032

Figure 35:  Asia Pacific Bacterial Vaccines Market Value Share (%), by Route of Administration, 2024

Figure 36:  Asia Pacific Bacterial Vaccines Market Value (USD billion), by Age Group, 2024 & 2032

Figure 37:  Asia Pacific Bacterial Vaccines Market Value Share (%), by Age Group, 2024

Figure 38:  Asia Pacific Bacterial Vaccines Market Value (USD billion), by Indication, 2024 & 2032

Figure 39:  Asia Pacific Bacterial Vaccines Market Value Share (%), by Indication, 2024

Figure 40:  Asia Pacific Bacterial Vaccines Market Value (USD billion), by Distribution Channel, 2024 & 2032

Figure 41:  Asia Pacific Bacterial Vaccines Market Value Share (%), by Distribution Channel, 2024

Figure 42:  Asia Pacific Bacterial Vaccines Market Value (USD billion), By Country/ Sub-region, 2024 & 2032

Figure 43:  Asia Pacific Bacterial Vaccines Market Value Share (%), By Country/ Sub-region, 2024

Figure 44:  Latin America Bacterial Vaccines Market Value (USD billion), by Type, 2024 & 2032

Figure 45:  Latin America Bacterial Vaccines Market Value Share (%), by Type, 2024

Figure 46:  Latin America Bacterial Vaccines Market Value (USD billion), by Route of Administration, 2024 & 2032

Figure 47:  Latin America Bacterial Vaccines Market Value Share (%), by Route of Administration, 2024

Figure 48:  Latin America Bacterial Vaccines Market Value (USD billion), by Age Group, 2024 & 2032

Figure 49:  Latin America Bacterial Vaccines Market Value Share (%), by Age Group, 2024

Figure 50:  Latin America Bacterial Vaccines Market Value (USD billion), by Indication, 2024 & 2032

Figure 51:  Latin America Bacterial Vaccines Market Value Share (%), by Indication, 2024

Figure 52:  Latin America Bacterial Vaccines Market Value (USD billion), by Distribution Channel, 2024 & 2032

Figure 53:  Latin America Bacterial Vaccines Market Value Share (%), by Distribution Channel, 2024

Figure 54:  Latin America Bacterial Vaccines Market Value (USD billion), By Country/ Sub-region, 2024 & 2032

Figure 55:  Latin America Bacterial Vaccines Market Value Share (%), By Country/ Sub-region, 2024

Figure 56:  Middle East & Africa Bacterial Vaccines Market Value (USD billion), by Type, 2024 & 2032

Figure 57:  Middle East & Africa Bacterial Vaccines Market Value Share (%), by Type, 2024

Figure 58:  Middle East & Africa Bacterial Vaccines Market Value (USD billion), by Route of Administration, 2024 & 2032

Figure 59:  Middle East & Africa Bacterial Vaccines Market Value Share (%), by Route of Administration, 2024

Figure 60:  Middle East & Africa Bacterial Vaccines Market Value (USD billion), by Age Group, 2024 & 2032

Figure 61:  Middle East & Africa Bacterial Vaccines Market Value Share (%), by Age Group, 2024

Figure 62:  Middle East & Africa Bacterial Vaccines Market Value (USD billion), by Indication, 2024 & 2032

Figure 63:  Middle East & Africa Bacterial Vaccines Market Value Share (%), by Indication, 2024

Figure 64:  Middle East & Africa Bacterial Vaccines Market Value (USD billion), by Distribution Channel, 2024 & 2032

Figure 65:  Middle East & Africa Bacterial Vaccines Market Value Share (%), by Distribution Channel, 2024

Figure 66:  Middle East & Africa Bacterial Vaccines Market Value (USD billion), By Country/ Sub-region, 2024 & 2032

Figure 67:  Middle East & Africa Bacterial Vaccines Market Value Share (%), By Country/ Sub-region, 2024

Figure 68:  Global Bacterial Vaccines Market Share (%), By Company, 2024

Table 1:  Global Bacterial Vaccines Market Revenue (USD billion) Forecast, by Type, 2019–2032

Table 2:  Global Bacterial Vaccines Market Revenue (USD billion) Forecast, by Route of Administration, 2019–2032

Table 3:  Global Bacterial Vaccines Market Revenue (USD billion) Forecast, by Age Group, 2019–2033

Table 4:  Global Bacterial Vaccines Market Revenue (USD billion) Forecast, by Indication, 2019–2034

Table 5:  Global Bacterial Vaccines Market Revenue (USD billion) Forecast, by Distribution Channel, 2019–2032

Table 6:  Global Bacterial Vaccines Market Revenue (USD billion) Forecast, by Region, 2019-2032

Table 7:  North America Bacterial Vaccines Market Revenue (USD billion) Forecast, by Type, 2019–2032

Table 8:  North America Bacterial Vaccines Market Revenue (USD billion) Forecast, by Route of Administration, 2019–2032

Table 9:  North America Bacterial Vaccines Market Revenue (USD billion) Forecast, by Age Group, 2019–2032

Table 10:  North America Bacterial Vaccines Market Revenue (USD billion) Forecast, by Indication, 2019–2032

Table 11:  North America Bacterial Vaccines Market Revenue (USD billion) Forecast, by Distribution Channel, 2019–2032

Table 12:  North America Bacterial Vaccines Market Revenue (USD billion) Forecast, By Country, 2019-2032

Table 13:  Europe Bacterial Vaccines Market Revenue (USD billion) Forecast, by Type, 2019–2032

Table 14:  Europe Bacterial Vaccines Market Revenue (USD billion) Forecast, by Route of Administration, 2019–2032

Table 15:  Europe Bacterial Vaccines Market Revenue (USD billion) Forecast, by Age Group, 2019–2032

Table 16:  Europe Bacterial Vaccines Market Revenue (USD billion) Forecast, by Indication, 2019–2032

Table 17:  Europe Bacterial Vaccines Market Revenue (USD billion) Forecast, by Distribution Channel, 2019–2032

Table 18:  Europe Bacterial Vaccines Market Revenue (USD billion) Forecast, By Country, 2019-2032

Table 19:  Asia Pacific Bacterial Vaccines Market Revenue (USD billion) Forecast, by Type, 2019–2032

Table 20:  Asia Pacific Bacterial Vaccines Market Revenue (USD billion) Forecast, by Route of Administration, 2019–2032

Table 21:  Asia Pacific Bacterial Vaccines Market Revenue (USD billion) Forecast, by Age Group, 2019–2032

Table 22:  Asia Pacific Bacterial Vaccines Market Revenue (USD billion) Forecast, by Indication, 2019–2032

Table 23:  Asia Pacific Bacterial Vaccines Market Revenue (USD billion) Forecast, by Distribution Channel, 2019–2032

Table 24:  Asia Pacific Bacterial Vaccines Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2019-2032

Table 25:  Latin America Bacterial Vaccines Market Revenue (USD billion) Forecast, by Type, 2019–2032

Table 26:  Latin America Bacterial Vaccines Market Revenue (USD billion) Forecast, by Route of Administration, 2019–2032

Table 27:  Latin America Bacterial Vaccines Market Revenue (USD billion) Forecast, by Age Group, 2019–2032

Table 28:  Latin America Bacterial Vaccines Market Revenue (USD billion) Forecast, by Indication, 2019–2032

Table 29:  Latin America Bacterial Vaccines Market Revenue (USD billion) Forecast, by Distribution Channel, 2019–2032

Table 30:  Latin America Bacterial Vaccines Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2019-2032

Table 31:  Middle East & Africa Bacterial Vaccines Market Revenue (USD billion) Forecast, by Type, 2019–2032

Table 32:  Middle East & Africa Bacterial Vaccines Market Revenue (USD billion) Forecast, by Route of Administration, 2019–2032

Table 33:  Middle East & Africa Bacterial Vaccines Market Revenue (USD billion) Forecast, by Age Group, 2019–2032

Table 34:  Middle East & Africa Bacterial Vaccines Market Revenue (USD billion) Forecast, by Indication, 2019–2032

Table 35:  Middle East & Africa Bacterial Vaccines Market Revenue (USD billion) Forecast, by Distribution Channel, 2019–2032

Table 36:  Middle East & Africa Bacterial Vaccines Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2019-2032

Bacterial Vaccines Market
  • 2019-2032
  • 2024
  • 2019-2023
  • 170
Download Free Sample

    man icon
    Mail icon
    Captcha refresh
Growth Advisory Services
    How can we help you uncover new opportunities and scale faster?
Clients
3M
Toshiba
Fresenius
Johnson
Siemens
Abbot
Allergan
American Medical Association
Becton, Dickinson and Company
Bristol-Myers Squibb Company
Henry Schein
Mckesson
Mindray
National Institutes of Health (NIH)
Nihon Kohden
Olympus
Quest Diagnostics
Sanofi
Smith & Nephew
Straumann

Related Reports